These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17680969)

  • 21. Bier anemic spots, cyanosis, and urticaria-like eruption (BASCULE) syndrome in a 15-year-old male, responsive to high-dose fexofenadine.
    Keeling E; Cotter C; O'Mahony S; Andrawis M; Salim A
    Pediatr Dermatol; 2024; 41(4):731-732. PubMed ID: 38413126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of alopecia areata responsive to fexofenadine.
    Inui S; Nakajima T; Itami S
    J Dermatol; 2007 Dec; 34(12):852-4. PubMed ID: 18078416
    [No Abstract]   [Full Text] [Related]  

  • 23. Procainamide-induced urticarial vasculitis.
    Knox JP; Welykyj SE; Gradini R; Massa MC
    Cutis; 1988 Nov; 42(5):469-72. PubMed ID: 2973973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of treatment of cefaclor-associated urticarial, serum sickness-like reactions and erythema multiforme by emergency pediatricians: lack of a uniform standard of care.
    Joubert GI; Hadad K; Matsui D; Gloor J; Rieder MJ
    Can J Clin Pharmacol; 1999; 6(4):197-201. PubMed ID: 10601753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urticarial vasculitis: a paraneoplastic presentation of B-cell non-Hodgkin's lymphoma.
    Wilson D; McCluggage WG; Wright GD
    Rheumatology (Oxford); 2002 Apr; 41(4):476-7. PubMed ID: 11961187
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urticaria vasculitis and sulfone, a case report].
    Wozel G; Thiele B
    Z Hautkr; 1987 Mar; 62(5):407-9. PubMed ID: 3590913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra.
    Botsios C; Sfriso P; Punzi L; Todesco S
    Scand J Rheumatol; 2007; 36(3):236-7. PubMed ID: 17657682
    [No Abstract]   [Full Text] [Related]  

  • 28. Urticarial vasculitis: a unique presentation.
    Stigall LE; Sigmon JR; Leicht SS
    South Med J; 2009 May; 102(5):531-3. PubMed ID: 19373142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annular leucocytoclastic vasculitis.
    Imanishi H; Tsuruta D; Ishii M; Kobayashi H
    Clin Exp Dermatol; 2009 Jul; 34(5):e120-2. PubMed ID: 19508466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypocomplementemic urticarial vasculitis with Jaccoud's arthropathy and valvular heart disease: case report and review of the literature.
    Amano H; Furuhata N; Tamura N; Tokano Y; Takasaki Y
    Lupus; 2008 Sep; 17(9):837-41. PubMed ID: 18755866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allergy to formaldehyde].
    Adamowicz Z; Doboszyńska A; Tomaszewska I; Siemieniuk A
    Pol Merkur Lekarski; 2004 Sep; 17(99):271-2. PubMed ID: 15628056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cetirizine hydrochloride-based therapeutic strategy for chronic urticaria.
    Sugiura K; Hirai S; Suzuki T; Usuda T; Kondo T; Azumi T; Masaki S; Yokoi T; Nitta Y; Kamiya S; Ando K; Mori T; Tomita Y
    Nagoya J Med Sci; 2008 Aug; 70(3-4):97-106. PubMed ID: 18954028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory urticarial vasculitis responsive to anti-B-cell therapy.
    Mukhtyar C; Misbah S; Wilkinson J; Wordsworth P
    Br J Dermatol; 2009 Feb; 160(2):470-2. PubMed ID: 19120327
    [No Abstract]   [Full Text] [Related]  

  • 34. Localized heat urticaria: Positive reaction of preheated autologous serum skin test.
    Hama N; Shimomura Y; Arinami H; Maruyama R; Abe R
    J Dermatol; 2016 Sep; 43(9):1099-100. PubMed ID: 26970386
    [No Abstract]   [Full Text] [Related]  

  • 35. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
    Highet AS
    Br J Dermatol; 1980 Mar; 102(3):358-60. PubMed ID: 7370185
    [No Abstract]   [Full Text] [Related]  

  • 36. [Urticarial vasculitis associated with essential thrombocythaemia progressing to myelofibrosis].
    Koudoukpo C; Jachiet M; Zini JM; Andreoli A; Pinquier L; Rybojad M; Bosset D; de Masson A; Bagot M; Lebbé C; Bouaziz JD
    Ann Dermatol Venereol; 2014 Dec; 141(12):773-6. PubMed ID: 25433930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypocomplementemic urticarial vasculitis].
    Sukenik S; Katz A; Avinoach I
    Harefuah; 1985 Nov; 109(9):233-5. PubMed ID: 4093068
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypersensitive urticarial vasculitis after natisedine intake].
    Loche F; Laplanche G; Bazex J
    Ann Dermatol Venereol; 1997; 124(6-7):457-9. PubMed ID: 9739909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zoledronate induced urticarial vasculitis.
    Swarnkar B; Biswal S; Agarwal S; Gupta S
    Dermatol Ther; 2021 Nov; 34(6):e15164. PubMed ID: 34676651
    [No Abstract]   [Full Text] [Related]  

  • 40. Case of intractable ophiasis type of alopecia areata presumably improved by fexofenadine.
    Nonomura Y; Otsuka A; Miyachi Y; Kabashima K
    J Dermatol; 2012 Dec; 39(12):1063-4. PubMed ID: 22594793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.